ID   MECP2_RAT               Reviewed;         492 AA.
AC   Q00566; Q09HV7; Q09HV8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   02-OCT-2024, entry version 182.
DE   RecName: Full=Methyl-CpG-binding protein 2;
DE            Short=MeCp-2 protein;
DE            Short=MeCp2;
GN   Name=Mecp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Wistar; TISSUE=Brain, and Corpus striatum;
RX   PubMed=1606614; DOI=10.1016/0092-8674(92)90610-o;
RA   Lewis J.D., Meehan R.R., Henzel W.J., Maurer-Fogy I., Jeppesen P.,
RA   Klein F., Bird A.;
RT   "Purification, sequence, and cellular localization of a novel chromosomal
RT   protein that binds to methylated DNA.";
RL   Cell 69:905-914(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), SUBCELLULAR LOCATION, AND
RP   INDUCTION BY FLUOXETINE AND COCAINE.
RC   STRAIN=Wistar; TISSUE=Brain cortex;
RX   PubMed=16670375; DOI=10.1124/mol.106.022301;
RA   Cassel S., Carouge D., Gensburger C., Anglard P., Burgun C.,
RA   Dietrich J.-B., Aunis D., Zwiller J.;
RT   "Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in
RT   adult rat brain.";
RL   Mol. Pharmacol. 70:487-492(2006).
RN   [3]
RP   PHOSPHORYLATION AT SER-80; SER-229 AND SER-421, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17046689; DOI=10.1016/j.neuron.2006.09.037;
RA   Zhou Z., Hong E.J., Cohen S., Zhao W.-N., Ho H.H., Schmidt L., Chen W.G.,
RA   Lin Y., Savner E., Griffith E.C., Hu L., Steen J.A.J., Weitz C.J.,
RA   Greenberg M.E.;
RT   "Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf
RT   transcription, dendritic growth, and spine maturation.";
RL   Neuron 52:255-269(2006).
RN   [4]
RP   INTERACTION WITH ATRX.
RX   PubMed=17296936; DOI=10.1073/pnas.0608056104;
RA   Nan X., Hou J., Maclean A., Nasir J., Lafuente M.J., Shu X.,
RA   Kriaucionis S., Bird A.;
RT   "Interaction between chromatin proteins MECP2 and ATRX is disrupted by
RT   mutations that cause inherited mental retardation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2709-2714(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13; SER-80 AND SER-229, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Chromosomal protein that binds to methylated DNA. It can bind
CC       specifically to a single methyl-CpG pair. It is not influenced by
CC       sequences flanking the methyl-CpGs. Mediates transcriptional repression
CC       through interaction with histone deacetylase and the corepressor SIN3A.
CC       Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-
CC       containing DNA, with a preference for 5-methylcytosine (5mC).
CC       {ECO:0000250|UniProtKB:Q9Z2D6}.
CC   -!- SUBUNIT: Interacts with FNBP3 (By similarity). Interacts with CDKL5 (By
CC       similarity). Interacts with ATRX; MECP2 recruits ATRX to pericentric
CC       heterochromatin in neuronal cells (PubMed:17296936). Interacts with
CC       NCOR2 (By similarity). Interacts with TBL1XR1; bridges interaction
CC       between MECP2 and NCOR1. Interacts with TBL1X; recruits TBL1X to the
CC       heterochromatin foci (By similarity). {ECO:0000250|UniProtKB:P51608,
CC       ECO:0000250|UniProtKB:Q9Z2D6, ECO:0000269|PubMed:17296936}.
CC   -!- INTERACTION:
CC       Q00566; Q00566: Mecp2; NbExp=5; IntAct=EBI-9396907, EBI-9396907;
CC       Q00566; P46100: ATRX; Xeno; NbExp=5; IntAct=EBI-9396907, EBI-396461;
CC       Q00566; Q9Z2E1: Mbd2; Xeno; NbExp=9; IntAct=EBI-9396907, EBI-5716946;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16670375}.
CC       Note=Colocalized with methyl-CpG in the genome. Colocalized with TBL1X
CC       to the heterochromatin foci. {ECO:0000250|UniProtKB:P51608}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A; Synonyms=e2;
CC         IsoId=Q00566-1; Sequence=Displayed;
CC       Name=B; Synonyms=e1;
CC         IsoId=Q00566-2; Sequence=VSP_022950;
CC   -!- TISSUE SPECIFICITY: Present in all adult somatic tissues tested.
CC   -!- INDUCTION: In brain, by repeated injections of fluoxetine or cocaine.
CC       {ECO:0000269|PubMed:16670375}.
CC   -!- PTM: Phosphorylated on Ser-421 by CaMK2 in brain upon synaptic
CC       activity, which attenuates its repressor activity and seems to regulate
CC       dendritic growth and spine maturation. {ECO:0000269|PubMed:17046689}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94064; AAA41584.1; -; mRNA.
DR   EMBL; DQ897368; ABI55237.1; -; mRNA.
DR   EMBL; DQ897369; ABI55238.1; -; mRNA.
DR   PIR; A41907; A41907.
DR   RefSeq; NP_073164.2; NM_022673.2.
DR   RefSeq; XP_006229629.1; XM_006229567.3.
DR   AlphaFoldDB; Q00566; -.
DR   BMRB; Q00566; -.
DR   SMR; Q00566; -.
DR   BioGRID; 248038; 3.
DR   CORUM; Q00566; -.
DR   DIP; DIP-60875N; -.
DR   IntAct; Q00566; 5.
DR   MINT; Q00566; -.
DR   STRING; 10116.ENSRNOP00000069913; -.
DR   GlyGen; Q00566; 10 sites, 1 O-linked glycan (10 sites).
DR   iPTMnet; Q00566; -.
DR   PhosphoSitePlus; Q00566; -.
DR   PaxDb; 10116-ENSRNOP00000053166; -.
DR   ABCD; Q00566; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000106335.1; ENSRNOP00000094658.1; ENSRNOG00000056659.2. [Q00566-2]
DR   GeneID; 29386; -.
DR   KEGG; rno:29386; -.
DR   AGR; RGD:3075; -.
DR   CTD; 4204; -.
DR   RGD; 3075; Mecp2.
DR   eggNOG; KOG4161; Eukaryota.
DR   GeneTree; ENSGT00530000063687; -.
DR   InParanoid; Q00566; -.
DR   OMA; PYKHERK; -.
DR   OrthoDB; 5262043at2759; -.
DR   PhylomeDB; Q00566; -.
DR   TreeFam; TF332974; -.
DR   Reactome; R-RNO-9022692; Regulation of MECP2 expression and activity. [Q00566-2]
DR   PRO; PR:Q00566; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0000792; C:heterochromatin; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0010385; F:double-stranded methylated DNA binding; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0000400; F:four-way junction DNA binding; IDA:RGD.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:RGD.
DR   GO; GO:0140566; F:histone reader activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008327; F:methyl-CpG binding; IDA:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; ISO:RGD.
DR   GO; GO:0003729; F:mRNA binding; ISO:RGD.
DR   GO; GO:0003676; F:nucleic acid binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0035197; F:siRNA binding; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0045322; F:unmethylated CpG binding; IDA:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; ISO:RGD.
DR   GO; GO:0001662; P:behavioral fear response; ISO:RGD.
DR   GO; GO:0006576; P:biogenic amine metabolic process; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0032048; P:cardiolipin metabolic process; ISO:RGD.
DR   GO; GO:0050432; P:catecholamine secretion; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071317; P:cellular response to isoquinoline alkaloid; IDA:RGD.
DR   GO; GO:0035865; P:cellular response to potassium ion; IDA:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0016358; P:dendrite development; ISO:RGD.
DR   GO; GO:0040029; P:epigenetic regulation of gene expression; IMP:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0071514; P:genomic imprinting; ISO:RGD.
DR   GO; GO:0014009; P:glial cell proliferation; ISO:RGD.
DR   GO; GO:0008211; P:glucocorticoid metabolic process; ISO:RGD.
DR   GO; GO:0006541; P:glutamine metabolic process; ISO:RGD.
DR   GO; GO:0031507; P:heterochromatin formation; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0006020; P:inositol metabolic process; ISO:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007616; P:long-term memory; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; IEP:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0033555; P:multicellular organismal response to stress; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0048712; P:negative regulation of astrocyte differentiation; IDA:RGD.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:1903860; P:negative regulation of dendrite extension; IMP:RGD.
DR   GO; GO:0061000; P:negative regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:RGD.
DR   GO; GO:0044027; P:negative regulation of gene expression via chromosomal CpG island methylation; ISO:RGD.
DR   GO; GO:0090327; P:negative regulation of locomotion involved in locomotory behavior; IMP:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:2000635; P:negative regulation of primary miRNA processing; IMP:RGD.
DR   GO; GO:1903941; P:negative regulation of respiratory gaseous exchange; IMP:RGD.
DR   GO; GO:0051151; P:negative regulation of smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0001976; P:nervous system process involved in regulation of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0050905; P:neuromuscular process; ISO:RGD.
DR   GO; GO:0050884; P:neuromuscular process controlling posture; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0007219; P:Notch signaling pathway; ISO:RGD.
DR   GO; GO:0021772; P:olfactory bulb development; IEP:RGD.
DR   GO; GO:0014003; P:oligodendrocyte development; IEP:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; ISO:RGD.
DR   GO; GO:1901953; P:positive regulation of anterograde dense core granule transport; IMP:RGD.
DR   GO; GO:1905492; P:positive regulation of branching morphogenesis of a nerve; IMP:RGD.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; IMP:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; ISO:RGD.
DR   GO; GO:0090063; P:positive regulation of microtubule nucleation; ISO:RGD.
DR   GO; GO:1901956; P:positive regulation of retrograde dense core granule transport; IMP:RGD.
DR   GO; GO:0031915; P:positive regulation of synaptic plasticity; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0021740; P:principal sensory nucleus of trigeminal nerve development; IEP:RGD.
DR   GO; GO:0019230; P:proprioception; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0099611; P:regulation of action potential firing threshold; IMP:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; ISO:RGD.
DR   GO; GO:0050807; P:regulation of synapse organization; IDA:SynGO.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007585; P:respiratory gaseous exchange by respiratory system; ISO:RGD.
DR   GO; GO:0097305; P:response to alcohol; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0010212; P:response to ionizing radiation; IEP:RGD.
DR   GO; GO:0010288; P:response to lead ion; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0051707; P:response to other organism; ISO:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   GO; GO:0035176; P:social behavior; IMP:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0021756; P:striatum development; IEP:RGD.
DR   GO; GO:0007416; P:synapse assembly; ISO:RGD.
DR   GO; GO:0021794; P:thalamus development; IEP:RGD.
DR   GO; GO:0099191; P:trans-synaptic signaling by BDNF; ISO:RGD.
DR   GO; GO:0003229; P:ventricular cardiac muscle tissue development; IEP:RGD.
DR   GO; GO:0021591; P:ventricular system development; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   CDD; cd01396; MeCP2_MBD; 1.
DR   InterPro; IPR016177; DNA-bd_dom_sf.
DR   InterPro; IPR017353; Me_CpG-bd_MeCP2.
DR   InterPro; IPR045138; MeCP2/MBD4.
DR   InterPro; IPR001739; Methyl_CpG_DNA-bd.
DR   PANTHER; PTHR15074; METHYL-CPG-BINDING PROTEIN; 1.
DR   PANTHER; PTHR15074:SF6; METHYL-CPG-BINDING PROTEIN 2; 1.
DR   Pfam; PF01429; MBD; 1.
DR   PIRSF; PIRSF038006; Methyl_CpG_bd_MeCP2; 1.
DR   SMART; SM00391; MBD; 1.
DR   SUPFAM; SSF54171; DNA-binding domain; 1.
DR   PROSITE; PS50982; MBD; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Direct protein sequencing; DNA-binding;
KW   Methylation; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..492
FT                   /note="Methyl-CpG-binding protein 2"
FT                   /id="PRO_0000096348"
FT   DOMAIN          90..162
FT                   /note="MBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00338"
FT   DNA_BIND        185..197
FT                   /note="A.T hook 1"
FT   DNA_BIND        265..277
FT                   /note="A.T hook 2"
FT   REGION          1..119
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          147..218
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          250..275
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          269..309
FT                   /note="Interaction with NCOR2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2D6"
FT   REGION          285..309
FT                   /note="Interaction with TBL1XR1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2D6"
FT   REGION          325..492
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        8..49
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        83..109
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        251..267
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        378..398
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        438..453
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        454..492
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         80
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17046689,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51608"
FT   MOD_RES         162
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2D6"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51608"
FT   MOD_RES         229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17046689,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         321
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2D6"
FT   MOD_RES         421
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000269|PubMed:17046689"
FT   MOD_RES         424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51608"
FT   MOD_RES         455
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P51608"
FT   VAR_SEQ         1..10
FT                   /note="MVAGMLGLRK -> MAAAAAAAAAAAAAAAAAAAAAAAAPSGGGGGEEERLE
FT                   (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:16670375"
FT                   /id="VSP_022950"
FT   CONFLICT        10
FT                   /note="K -> E (in Ref. 2; ABI55238)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   492 AA;  53047 MW;  A67E705C68BA2D38 CRC64;
     MVAGMLGLRK EKSEDQDLQG LKEKPLKFKK VKKDKKEDKE GKHEPLQPSA HHSAEPAEAG
     KAETSESSGS APAVPEASAS PKQRRSIIRD RGPMYDDPTL PEGWTRKLKQ RKSGRSAGKY
     DVYLINPQGK AFRSKVELIA YFEKVGDTSL DPNDFDFTVT GRGSPSRREQ KPPKKPKSPK
     APGTGRGRGR PKGSGTGRPK AAASEGVQVK RVLEKSPGKL LVKMPFQASP GGKGEGGGAT
     TSAQVMVIKR PGRKRKAEAD PQAIPKKRGR KPGSVVAAAA AEAKKKAVKE SSIRSVQETV
     LPIKKRKTRE TVSIEVKEVV KPLLVSTLGE KSGKGLKTCK SPGRKSKESS PKGRSSSASS
     PPKKEHHHHH HHAESPKAPM PLLPPPPPPE PQSSEDPISP PEPQDLSSSI CKEEKMPRAG
     SLESDGCPKE PAKTQPMVAA AATTTTTTTT TVAEKYKHRG EGERKDIVSS SMPRPNREEP
     VDSRTPVTER VS
//
